Emergent BioSolutions (EBS) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $7.85 --0%
EPS Growth %: -31.3%
Financial Fact:
Other income (expense), net: -234K
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -31.3%
Financial Fact:
Other income (expense), net: -234K
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $192.5 million versus the consensus estimate of $199.47 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- NVE Corporation names new CEO and expands board to seven members
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
